Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics. The company has one operating segment: researching, developing, manufacturing and distributing innovative evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
2018
30
LTM Revenue $13.3M
LTM EBITDA $0.8M
$68.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of August 2025, Biome Australia reported last 12-month revenue of $13.3M and EBITDA of $0.8M.
In the same period, Biome Australia generated $8.1M in LTM gross profit and $0.6M in net income.
See Biome Australia valuation multiples based on analyst estimatesIn the most recent fiscal year, Biome Australia reported revenue of $8.5M and EBITDA of -$0.8M.
Biome Australia expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Biome Australia valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $13.3M | XXX | $8.5M | XXX | XXX | XXX |
Gross Profit | $8.1M | XXX | $5.2M | XXX | XXX | XXX |
Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
EBITDA | $0.8M | XXX | -$0.8M | XXX | XXX | XXX |
EBITDA Margin | 6% | XXX | -10% | XXX | XXX | XXX |
EBIT | $0.7M | XXX | -$1.3M | XXX | XXX | XXX |
EBIT Margin | 5% | XXX | -15% | XXX | XXX | XXX |
Net Profit | $0.6M | XXX | -$1.1M | XXX | XXX | XXX |
Net Margin | 5% | XXX | -13% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Biome Australia has current market cap of AUD 105M (or $68.7M), and EV of AUD 105M (or $68.9M).
As of September 19, 2025, Biome Australia's stock price is AUD 0 (or $0).
See Biome Australia trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$68.9M | $68.7M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialBiome Australia's trades at 10.4x EV/Revenue multiple, and -52.0x EV/EBITDA.
See valuation multiples for Biome Australia and 15K+ public compsAs of September 19, 2025, Biome Australia has market cap of $68.7M and EV of $68.9M.
Equity research analysts estimate Biome Australia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biome Australia has a P/E ratio of 113.7x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $68.7M | XXX | $68.7M | XXX | XXX | XXX |
EV (current) | $68.9M | XXX | $68.9M | XXX | XXX | XXX |
EV/Revenue | 5.2x | XXX | 10.4x | XXX | XXX | XXX |
EV/EBITDA | 83.8x | XXX | -52.0x | XXX | XXX | XXX |
EV/EBIT | 104.1x | XXX | -39.8x | XXX | XXX | XXX |
EV/Gross Profit | 8.5x | XXX | n/a | XXX | XXX | XXX |
P/E | 113.7x | XXX | -44.1x | XXX | XXX | XXX |
EV/FCF | -61.8x | XXX | -51.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBiome Australia's last 12 month revenue growth is 43%
Biome Australia's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Biome Australia's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Biome Australia's rule of X is 113% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Biome Australia and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 43% | XXX | 77% | XXX | XXX | XXX |
EBITDA Margin | 6% | XXX | -20% | XXX | XXX | XXX |
EBITDA Growth | 282% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | 23% | XXX | 23% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 113% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 76% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Vita Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
Mega Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
Procter & Gamble Health | XXX | XXX | XXX | XXX | XXX | XXX |
Abbott India | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biome Australia acquired XXX companies to date.
Last acquisition by Biome Australia was XXXXXXXX, XXXXX XXXXX XXXXXX . Biome Australia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Biome Australia founded? | Biome Australia was founded in 2018. |
Where is Biome Australia headquartered? | Biome Australia is headquartered in Australia. |
How many employees does Biome Australia have? | As of today, Biome Australia has 30 employees. |
Is Biome Australia publicy listed? | Yes, Biome Australia is a public company listed on ASX. |
What is the stock symbol of Biome Australia? | Biome Australia trades under BIO ticker. |
When did Biome Australia go public? | Biome Australia went public in 2021. |
Who are competitors of Biome Australia? | Similar companies to Biome Australia include e.g. Vita Life Sciences, SynBiotic, Mega Lifesciences, Procter & Gamble Health. |
What is the current market cap of Biome Australia? | Biome Australia's current market cap is $68.7M |
What is the current revenue of Biome Australia? | Biome Australia's last 12 months revenue is $13.3M. |
What is the current revenue growth of Biome Australia? | Biome Australia revenue growth (NTM/LTM) is 43%. |
What is the current EV/Revenue multiple of Biome Australia? | Current revenue multiple of Biome Australia is 5.2x. |
Is Biome Australia profitable? | Yes, Biome Australia is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Biome Australia? | Biome Australia's last 12 months EBITDA is $0.8M. |
What is Biome Australia's EBITDA margin? | Biome Australia's last 12 months EBITDA margin is 6%. |
What is the current EV/EBITDA multiple of Biome Australia? | Current EBITDA multiple of Biome Australia is 83.8x. |
What is the current FCF of Biome Australia? | Biome Australia's last 12 months FCF is -$1.1M. |
What is Biome Australia's FCF margin? | Biome Australia's last 12 months FCF margin is -8%. |
What is the current EV/FCF multiple of Biome Australia? | Current FCF multiple of Biome Australia is -61.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.